Acquisition of Abcam (ABCM) by Danaher (DHR) Approved by the High Court of Justice of England and Wales Dec 4, 2023 04:01PM
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales Dec 4, 2023 04:01PM
Abcam (ABCM) Acquisition by Danaher (DHR) Has Received All Identified Clearances; Transaction Expected to Close on December 6 Nov 17, 2023 07:03AM
Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023 Nov 17, 2023 07:00AM
Abcam (ABCM) Shareholders Approve Proposed Acquisition by Danaher (DHR) Nov 6, 2023 04:00PM


Nov 6, 2023 04:00PM Shareholders of Abcam Approve Proposed Acquisition by Danaher
Oct 23, 2023 07:30AM Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam
Oct 17, 2023 07:30AM Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam
Oct 12, 2023 07:30AM Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher
Oct 5, 2023 08:00AM Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share
Sep 14, 2023 06:59PM Abcam plc Statement on Dr. Jonathan Milner’s Announcement
Aug 28, 2023 07:35AM Danaher to acquire Abcam for $24.00 per Share
Jun 23, 2023 08:03AM Abcam (ABCM) Announces Review of Strategic Alternatives, Including Potential Sale
Jun 23, 2023 08:01AM Abcam Announces Review of Strategic Alternatives
Jun 16, 2023 06:37AM Abcam plc files and mails Shareholder Circular calling an Extraordinary General Meeting
Aug 2, 2021 05:48AM Abcam plc (ABCM) Acquires BioVision for $340M
Aug 2, 2021 02:00AM Abcam to Acquire BioVision for $340 million
Aug 2, 2021 02:00AM Abcam to Acquire BioVision for $340 million
Oct 26, 2020 11:45AM Abcam Announces Closing of Offering
Oct 22, 2020 02:00AM Abcam Announces Pricing of Offering on NASDAQ